Vanguards of Healthcare by Bloomberg Intelligence

Akido Labs CEO claims AI can deliver concierge-quality healthcare to all by breaking scarcity through Scope AI.

44 min Listen to the original Episode page
Artificial IntelligenceHealthcareValue-Based CareDigital HealthMedicaidCardiologyStreet Medicine

Summary

Akido Labs CEO Prashant Simant explains how the company evolved from a data platform to a full-stack care delivery organization to leverage predictive models for patient outcomes. He highlights Scope AI, a neural network enabling software-based cardiology visits and clinical decision support for non-medical case managers. Simant claims the system achieves 93.6% accuracy and has reduced emergency department utilization by 50% in their street medicine program. He predicts that within five years, AI and wearables will make high-quality healthcare accessible to everyone, similar to the 'Jeff Bezos model.' The company plans to expand to 50 markets, focusing on value-based care and partnerships in underserved populations.

Episode sections

  1. 0:18 – 2:19

    Introduction and Mission

    Jonathan Palmer introduces Prashant Simant, CEO of Akido Labs, which is building an AI-native health system. Simant describes the mission as providing concierge-quality care to all, aiming to break the link between poverty and poor health outcomes by rebuilding the safety net.

  2. 2:19 – 6:41

    Origin Story and Data Infrastructure

    Simant recounts his background in a medical household and volunteering at Alameda County Medical Center, which highlighted healthcare inequities. He explains that Akido started in 2015 at USC, initially focusing on organizing disparate healthcare data to build predictive models, evolving from a data platform to a care delivery business.

  3. 6:41 – 14:15

    Transition to Care Delivery and Scope AI

    Akido launched its own healthcare system to fully leverage its predictive models and automate care. In 2024, they developed Scope AI, a neural network platform that enables the country's first entirely software-based cardiology visit, aiming to increase provider capacity and prevent worsening health conditions.

  4. 14:15 – 18:28

    Scope AI Workflow and Clinical Accuracy

    Scope AI assists non-medical case managers in the field by orchestrating differential diagnoses via iPad or phone. It flags potential treatments like antibiotics or Suboxone prescriptions for provider approval. Simant claims Scope performs at 93.6% accuracy against a 'total addressable medical situation space' derived from their own clinical history.

  5. 18:28 – 23:07

    Scale, Partnerships, and Street Medicine

    Akido serves approximately one million patients across 96 locations, primarily in California, with a patient mix of 50% commercial, 25% Medicare, and 25% Medicaid. They partner with local hospitals like Pomona Valley Hospital for procedures. Their street medicine program, the largest in California, has achieved a 50% reduction in emergency department utilization among participants.

  6. 23:07 – 27:24

    KPIs and Value-Based Care Model

    The company tracks quality metrics, patient satisfaction (96% NPS), and cost per treatment/diagnosis. They are oriented toward preventative value-based care rather than fee-for-service, aiming to increase both provider capacity and patient touchpoints without sacrificing clinical attention.

  7. 27:24 – 33:22

    Data Advantage and Competitive Moat

    Simant argues Akido's advantage lies in its proprietary data: a comprehensive medical textbook, real-case investigative history for grading models, and a massive reinforcement learning loop from provider interactions. He claims this data moat prevents large health systems from easily replicating their model due to operational and physical constraints.

  8. 33:22 – 33:54

    Liability and Conclusion

    Regarding liability for AI decision support, Simant states that Akido maintains a 'physician in the loop' model. This structure ensures that providers carry the liability for final decisions, similar to a typical healthcare organization, rather than the AI system itself.

  9. 33:54 – 36:07

    Clinical Decision Support and System Design

    The speaker clarifies that the technology is designed as clinical decision support rather than a replacement for clinician judgment. The system captures extensive patient data across multiple dimensions to improve visibility into care quality and accountability.

  10. 36:07 – 39:15

    Expansion Strategy and Medicaid Context

    The speaker notes a growing appetite for change in healthcare due to shifts in the Medicaid ecosystem. Akido aims to expand to 50 markets in five years, starting with partnerships in specific geographies like New York.

  11. 39:15 – 41:03

    Future of Healthcare: The 'Jeff Bezos' Model

    The speaker predicts that within five years, every American will have access to high-quality healthcare comparable to Jeff Bezos's. This will be driven by AI and continuous monitoring via wearables, eliminating long wait times for specialists.

  12. 41:03 – 42:32

    Unlocking Practical Abundance in Care

    The speaker identifies the combination of wearable technology, cheaper diagnostics, and neural network models like Scope AI as the catalyst for making true value-based care a practical reality. This allows providers to monitor more patients effectively.

  13. 42:32 – 44:28

    Personal Mission and Background

    The speaker attributes his mission to his privileged education and his parents' sacrifices moving from India to America. He views providing high-quality developmental support and healthcare to all humans as a moral imperative.

Claims worth verifying

Akido Labs was co-founded in 2015 by Prashant Simant and Jared Goodner.

Unidentified speaker ·0:37

How to verify: Check Akido Labs' corporate registration records or press releases from 2015; verify Jared Goodner's co-founder status on LinkedIn or company leadership pages.

The American healthcare system costs $5.5 trillion.

Unidentified speaker ·4:53

How to verify: Verify against National Health Expenditure Accounts (NHEA) data published by the Centers for Medicare & Medicaid Services (CMS).

Akido's Scope AI performed at 93.6% accuracy against a 'total addressable medical situation space'.

Unidentified speaker ·19:03

How to verify: Request Akido Labs to publish the methodology and validation study for this metric; compare against independent clinical audits of AI diagnostic tools.

Akido serves approximately one million patients.

Unidentified speaker ·18:28

How to verify: Check Akido Labs' investor presentations, annual reports, or official press releases for patient volume metrics.

Akido has 96 locations primarily in California, Rhode Island, and New York.

Unidentified speaker ·19:48

How to verify: Verify via Akido Labs' website location finder or state health department facility licensing databases.

Akido's patient population is 50% commercial, 25% Medicare, and 25% Medicaid.

Unidentified speaker ·20:28

How to verify: Review Akido Labs' financial disclosures, payer mix reports, or investor presentations detailing revenue sources.

Akido's street medicine program has achieved a 50% reduction in emergency department (ED) utilization.

Unidentified speaker ·22:40

How to verify: Request Akido Labs to provide the clinical study or operational data supporting this reduction metric; verify through published health outcomes research.

Akido has the largest operational street medicine program in California.

Unidentified speaker ·21:45

How to verify: Compare Akido's program size (patient count, staff, visits) against other known street medicine programs in CA (e.g., Mission Neighborhood Centers, Street Medicine Institute) using public reports.

Akido achieved the country's first cardiology visit entirely in software.

Unidentified speaker ·13:07

How to verify: Search for press releases, medical journal publications, or FDA clearances regarding Akido's first fully digital cardiology consultation.

Frontier models only have access to 7% of healthcare data.

Unidentified speaker ·27:34

How to verify: Verify the source of this claim by checking Datavan's CEO's original statements or interviews; assess the definition of 'healthcare data' used in the calculation.

Akido's technology is designed as clinical decision support, not a replacement for clinician judgment.

Unidentified speaker ·

How to verify: Review Akido Labs' official product documentation or press releases describing their AI capabilities and intended use cases.

Akido aims to reach 50 markets in the next five years.

Unidentified speaker ·

How to verify: Check Akido Labs' official website, investor presentations, or press releases for stated expansion goals and timelines.

Akido is partnering with the Independent Drivers Guild for expansion in the New York region.

Unidentified speaker ·

How to verify: Search for press releases or partnership announcements from Akido Labs and the Independent Drivers Guild regarding healthcare initiatives in New York.

Within five years, every person in America will have access to healthcare quality comparable to Jeff Bezos's.

Unidentified speaker ·

How to verify: This is a subjective forecast; verify by tracking industry reports on healthcare accessibility and AI adoption rates over the next five years.

The speaker waited four to five months for a cardiology visit.

Unidentified speaker ·

How to verify: This is a personal anecdote; it cannot be independently verified as a general fact but reflects the speaker's personal experience.

Wearable technology and diagnostics are becoming cheaper and more highly available.

Unidentified speaker ·

How to verify: Review market research reports from firms like Gartner, IDC, or McKinsey on the cost trends of wearable health devices and diagnostic tools.

True value-based care is becoming a practical reality due to AI and monitoring technologies.

Unidentified speaker ·

How to verify: Analyze healthcare industry reports on the adoption of value-based care models and the integration of AI/wearables in provider workflows.

The speaker is the CEO and co-founder of Akido Labs.

Unidentified speaker ·

How to verify: Check Akido Labs' official website, LinkedIn profile of Prashant Simant, or company filings for leadership information.

Akido's system captures patient data across multiple dimensions to create a single source of truth.

Unidentified speaker ·

How to verify: Review Akido Labs' technical whitepapers or product descriptions detailing their data architecture and patient journey tracking capabilities.

Changes in the Medicaid ecosystem are driving a need for new healthcare solutions.

Unidentified speaker ·

How to verify: Review government reports, CMS (Centers for Medicare & Medicaid Services) publications, or healthcare industry analyses on recent Medicaid policy changes.

Do your own research

  • Verify the 93.6% accuracy claim by reviewing Akido Labs' clinical validation studies or peer-reviewed publications comparing Scope AI outputs against gold-standard diagnoses.
  • Check the 50% reduction in emergency department utilization by examining Akido's published outcomes data or third-party audits of their street medicine program.
  • Review Akido Labs' liability insurance policies and legal structures to confirm the 'physician in the loop' model and how liability is allocated between the company and providers.
  • Investigate Akido's partnerships with hospitals like Pomona Valley Hospital and their reimbursement models under Medicare, Medicaid, and commercial payers.
  • Assess the scalability of the 'Jeff Bezos model' by analyzing current adoption rates of wearable technology and AI integration in mainstream healthcare systems.
  • Examine Akido's expansion plans for the 50 markets target, including regulatory hurdles in new states like New York and existing competitive landscape.
  • Verify the size of Akido's proprietary dataset and the 'comprehensive medical textbook' claim by reviewing their data infrastructure disclosures or technical whitepapers.
Full transcriptexpand
0:18
Unidentified speaker: Welcome to another episode of Bloomberg Intelligence and his Vanguards of Healthcare podcast, where we speak with the leaders at the forefront of change in the healthcare industry.
0:26
Unidentified speaker: My name is Jonathan Palmer, and I'm a healthcare analyst at Bloomberg Intelligence, the in-house research arm of Bloomberg.
0:32
Unidentified speaker: I'm very excited to welcome Prashant Simant, co-founder and CEO of Akido Labs to the podcast today.
0:37
Unidentified speaker: Akido is building what they describe as an AI native health system, combining its scope AI technology with a growing clinical network to rethink how care is delivered.
0:47
Unidentified speaker: Prashant co-founded the company in 2015 after previously helping launch USC's digital health lab.
0:53
Unidentified speaker: And Akito has since evolved from a data health plat health data platform into a full-stack care delivery business focused in part on some of the most complex and underserved patient populations.
1:04
Unidentified speaker: There's a lot here to unpack around AI and the physician workforce and what the health system of the future looks like.
1:10
Unidentified speaker: Prashant, welcome to the podcast.
1:12
Unidentified speaker: Thank you, Jonathan.
1:13
Unidentified speaker: Great to have you here.
1:13
Unidentified speaker: Well, let's jump right in.
1:15
Unidentified speaker: How would you describe Akido's mission in just a few short sentences?
1:19
Unidentified speaker: So our mission is to do two interlocking things.
1:24
Unidentified speaker: One is to bring a world-class concierge quality healthcare to everybody.
1:30
Unidentified speaker: We live in a world of abundance.
1:32
Unidentified speaker: We're shifting more and more for that abundance being a practical reality.
1:36
Unidentified speaker: And we see our job as to make that care that might be reserved for people that have extraordinary means available to every individual person.
1:46
Unidentified speaker: And through that process, we also see it's possible to kind of break this inextricable tie between poverty and health care and healthcare consequences as a resulting drive towards more poverty.
2:01
Unidentified speaker: And so our focus is to tackle that underlying issue and rebuild the safety net so it's stronger, more equitable, more accessible.
2:19
Unidentified speaker: Well, my parents were both county doctors.
2:23
Unidentified speaker: So grew up in a Philippine medical household.
2:25
Unidentified speaker: My mom was a physician at Alameda County Medical Center in the 90s.
2:31
Unidentified speaker: She was a gynecologist there.
2:33
Unidentified speaker: And if you can think about, you know, Oakland in the 90s, it was a really dark, fascinating time.
2:40
Unidentified speaker: And I spent most of my summers volunteering there.
2:43
Unidentified speaker: And you just see uh you know this the the some of the practical aspects of health care and what makes healthcare so challenging up close.
2:51
Unidentified speaker: One, no matter how hard my mom works, no matter how hard her colleagues work, there just isn't enough available health care um for the people that that need it the most.
3:01
Unidentified speaker: Um and also, you know, it's the the the quality of care that people can get uh and the circumstances of their health are so different from from mine practically.
3:13
Unidentified speaker: So I'm I'm coming in from uh you know a life with some level of means into a county environment with some of where people are struggling very extensively, and it's it's not it's not you know possible to not wonder, you know, how come this population is dealing with so many more healthcare consequences than I am?
3:34
Unidentified speaker: Why is the zip code that they're in you know a strong predictor of their healthcare consequences?
3:40
Unidentified speaker: So it's very illuminating in that way.
3:42
Unidentified speaker: So where did the idea for keto germinate?
3:46
Unidentified speaker: You know, you had this background in technology and a family that's very uh entwined with the healthcare system.
3:51
Unidentified speaker: When did you decide to make that this your wife's work?
3:54
Unidentified speaker: So um, well, we started the company 10 years ago.
3:57
Unidentified speaker: And as you mentioned before that, we established the University of Southern California Digital Health Lab, which was USC CAC Medicines Innovation Center.
4:04
Unidentified speaker: Um did it at a really important time when electronic health records were being mandated and being installed.
4:10
Unidentified speaker: And so a lot of information was coming online for the first time.
4:13
Unidentified speaker: Um my co-founder and I, um Jared Goodner, uh Jared uh was doing his PhD in neural networks.
4:20
Unidentified speaker: He's a PhD dropout, so I think it's even cooler than having a PhD in neural networks.
4:25
Unidentified speaker: You know, we've historically focused on building organizations, nonprofit or for-profit organizations at the intersection of a social change uh around equity and technology.
4:36
Unidentified speaker: And, you know, just being exposed to how um uh intertwined uh healthcare is with equity, uh, you know, we felt strongly that you have this huge moment where a lot of data is coming online.
4:53
Unidentified speaker: Data can be utilized to better predict worsening health conditions, uh leverage to make better tools and technology to uh automate more care, increase the capacity uh of our healthcare workers, and maybe we can tackle uh how to better spend this $5.5 trillion that is uh part of the American healthcare system.
5:14
Unidentified speaker: Um and so starting the lab at USC was really a way to understand why the system works the way it does?
5:20
Unidentified speaker: What are the limiting steps in bringing this technology into this world?
5:24
Unidentified speaker: Um and so that was the origins of it.
5:26
Unidentified speaker: And from there, what did you decide you wanted to build first?
5:30
Unidentified speaker: So when we were at the University of the Southern California Digital Health Lab, it was really clear that data could be a answer to some of these challenges.
5:39
Unidentified speaker: Um, the challenges being how do we predict worsening health conditions better?
5:43
Unidentified speaker: And how can we make tools that enhance the capability of our healthcare workers so we can see more patients?
5:50
Unidentified speaker: Um but we saw that you know, a subset of data isn't enough.
5:54
Unidentified speaker: And we need to organize more and more and more data to be able to create more and more powerful models.
5:59
Unidentified speaker: So for the first five years of the company's history, uh, when we commercialized this out of the USCD Health Lab, we were focused on organizing those data sets and integrating more and more healthcare data to create a powerful platform.
6:14
Unidentified speaker: Then we built models on top of that platform that predict worsening health conditions and automate parts of the care process.
6:22
Unidentified speaker: During COVID, for instance, we were working with county governments, state organizations, um, the CDC, the FDA, uh to do things like disease hotspotting, figure out where code was going to pop up in certain populations, and uh the horsepower of our model, which is better because we had more data.
6:41
Unidentified speaker: Um, and that led us to launching our own health care system.
6:45
Unidentified speaker: If you can reimagine both primary and specialty care um leveraging these models that predict worse than health conditions and can automate parts of the care process, you can create a uh a next generation of whole person care for these patients and do so in a way that's truly preventative.
7:02
Unidentified speaker: Um, bring that same kind of care that uh you know somebody with means might have to somebody that is just trying to get by.
7:10
Unidentified speaker: I'll come back to the the decision to make uh you know care delivery part of the business plan.
7:15
Unidentified speaker: But if I think back to the data, I think the listeners of this podcast you know won't be surprised to know that you know EMRs are not for necessarily managing populations, they're really for billing.
7:25
Unidentified speaker: So where did you get the rest of the data that you were going to utilize in your models and how accessible was that?
7:30
Unidentified speaker: Because I I think of still the industry being very siloed.
7:34
Unidentified speaker: We've talked about interoperability for years, but we don't really have it.
7:37
Unidentified speaker: Yeah.
7:38
Unidentified speaker: Yeah.
7:38
Unidentified speaker: I mean, that's a really good question.
7:40
Unidentified speaker: Um and we saw this firsthand at USC.
7:42
Unidentified speaker: I mean, amazing people working at USC and KEC Medicine, you know, trying to make the most of this the server installation, which, as you as you mentioned, you know, these systems are built uh more for billing, um, more for the economics of healthcare as opposed to just using data for uh the best healthcare specific purposes.
8:01
Unidentified speaker: Um and so the underlying technology that we built, lab, was a really complex multimodal data integration and management system.
8:10
Unidentified speaker: Okay.
8:10
Unidentified speaker: Um and so when we first started as a private organization, we were funded by a fund called Y Combinator.
8:18
Unidentified speaker: Um and uh what we had talked to them about is like we're gonna use this technology to interface with a wide variety of different organizations and there's there's their source systems, EHR systems, social service systems.
8:30
Unidentified speaker: Um, we did a wide variety of different programs around the country that required stitching together various data sets, uh, interfacing very painfully with these source systems.
8:41
Unidentified speaker: Um, and initially providing that data for those programs, you know, for instance, coordinating care for people experiencing homelessness, you know, LAPD across Santa Monica, across four different hospitals, and enabling those programs.
8:55
Unidentified speaker: But as we're enabling those programs and interfacing with those different data sources, we're also organizing it, making it cleaner, making it longitudinal.
9:04
Unidentified speaker: Uh and so you can think about the first five years of this country's or of our company's um uh instantiation was you know interfacing with source systems around the country and cleaning and organizing that data, kind of like data plumbers.
9:20
Unidentified speaker: And was the vision at that point to ultimately do the care delivery, or were you thinking more that, you know, by having maybe these insights, you would have a different business model, maybe helping other systems or other care delivery?
9:32
Unidentified speaker: So we we felt that to get the most leverage out of this capability, being in care delivery would become essential.
9:42
Unidentified speaker: Okay.
9:42
Unidentified speaker: The question was when we're gonna get there.
9:45
Unidentified speaker: And uh and so, you know, I think we have a pretty unique story there where we were a data company uh and then a program provider on top of that, uh, and then a care delivery organization.
9:57
Unidentified speaker: Uh, but we wanted to be sure before we jumped into care delivery that we could bring differentiated technology and different capabilities into that process.
10:07
Unidentified speaker: But ultimately, um if you're not responsible for patients, uh if you're not the point guard of their care, it's it's difficult to leverage the insights that you can get um, you know, from predicting worsening health conditions, uh, or the horsepower you can get by from augmenting uh our care care providers.
10:28
Unidentified speaker: Uh it's difficult to leverage that to actually change what happens in those patients' lives.
10:33
Unidentified speaker: Um it's difficult to leverage that to be able to perform better in say risk sharing or value-based care contracts.
10:41
Unidentified speaker: That impact became really, really important.
10:44
Unidentified speaker: And we felt pretty strongly about that from the get-go.
10:47
Unidentified speaker: So, what did that first clinic where you're actually offering care look like?
10:51
Unidentified speaker: What were you offering at that time?
10:53
Unidentified speaker: And I imagine that the aperture has expanded quite a bit since then.
10:56
Unidentified speaker: Yeah, I mean, uh the this scope AI uh neural network platform in the arc of Aikido is relatively new.
11:07
Unidentified speaker: Um, the data infrastructure that enables it, you know, that's been something that we've been building and Dell from for quite some time.
11:14
Unidentified speaker: But when we first started in care delivery, the focus was more on what we refer to as population health management or again predicting worsening health conditions.
11:23
Unidentified speaker: Uh and so using um our models built on top of this data set to understand what might happen in a population that we're responsible for from a clinical standpoint, identifying uh a patient's worsening conditions earlier and intervening earlier.
11:40
Unidentified speaker: And when you're in uh a you know a contract where you're sharing some level of risk on that patient or you're being rewarded for um you know a value-based care approach, uh that knowledge is very powerful.
11:52
Unidentified speaker: Sure.
11:53
Unidentified speaker: Um, economically powerful and can create more leverage for your doctors.
11:56
Unidentified speaker: You can create more capacity with more capacity for your doctors by you know preventing disease uh in your population from from occurring.
12:04
Unidentified speaker: You can take care of more patients, then there's a positive feedback loop for being able to be able to uh create more and more um care for a population.
12:14
Unidentified speaker: It's no secret that we have an undersupply of care in this country and in any country.
12:22
Unidentified speaker: Um what became painstakingly obvious to us uh even you know as we were doing this uh this work around population health management was that that undersupply of care is the root cause issue for a lot of the challenges that we experience in the American healthcare system.
12:41
Unidentified speaker: Um and so come 2024, um neural network technology in general is getting better, uh transformer technology happens, the open AI moment happens, um, and we start investing more and more into the idea of clinical investigation uh enabled by our data set, um, built out that Scope AI technology, and you know, did the, to my knowledge, the country's first cardiology visit entirely in software.
13:10
Unidentified speaker: No, it's easy.
13:11
Unidentified speaker: And this was like a stealth project that we were working on for a minute.
13:14
Unidentified speaker: Um and the moment that I saw it happen, the full kind of differential diagnosis process happening um in software, I was like, this is gonna be the future.
13:24
Unidentified speaker: Um because if we can use that kind of technology to increase the capacity of a provider, you know, that is the holy grail, right?
13:34
Unidentified speaker: Uh preventing worsening health conditions is uh or being able to identify uh someone's worsening health conditions is very important and um can get some leverage.
13:45
Unidentified speaker: But being able to literally just create more and more care availability, I mean, that that is like a miracle.
13:52
Unidentified speaker: Um and so we started investing more and more into that direction, into that technology, uh, and then brought that uh AI-enabled care model to life uh late last year.
14:03
Unidentified speaker: That's great.
14:04
Unidentified speaker: Maybe just rewinding a little bit there, where does scope AI sit in the clinical workflow and and how does it, I guess, support you know, a patient doctor or clinician interaction?
14:15
Unidentified speaker: Or maybe it doesn't have to necessarily even be patient doctor.
14:18
Unidentified speaker: I'm sure there's a host of different workflows and use cases.
14:21
Unidentified speaker: Yeah.
14:21
Unidentified speaker: I mean, our goal, zooming out, our goal is to make sure that our providers uh are uh using their time um uh uh with the most effectiveness so that we can take care of the most situations that our patients face.
14:41
Unidentified speaker: Um and with a technology like Scope, we can uh divorce large parts of the clinical investigation process where it's reliance on a provider for every single occurrence.
14:52
Unidentified speaker: Uh and so a uh a person, uh whether it is a case manager who is taking care of maybe um one of our patients in the field, like a person expecting homelessness uh or a care manager, you know, not medically trained, but you know, trained um to be concerned, uh, can do a home call or house visit with a Medicare patient who's living with some chronic illness.
15:17
Unidentified speaker: Um that individual enabled by scope, um, say running on their iPad or on their phone uh can run a full clinical investigation uh prompted by scope with questions that the patient then answers.
15:32
Unidentified speaker: If the patient starts talking about their heart, scope will start prompting questions about their heart.
15:36
Unidentified speaker: If the patient starts talking about uh their kidneys, scope will start prompting questions about their kidneys.
15:42
Unidentified speaker: Basically, like a differential diagnosis process that is being orchestrated by scope upfront and independent from uh the clinical investigation process guided doctor might do.
15:55
Unidentified speaker: Um that unearths a tremendous amount of diagnostic awareness.
15:59
Unidentified speaker: You know, let's say you're in the field, a person experiencing homelessness might have been cut, uh, and you know, it's very clear that they need broad spectrum antibiotics.
16:08
Unidentified speaker: Scope will flag that as a potential order.
16:10
Unidentified speaker: Um, the patient might also be um uh you know open to entering into a uh boxone-enabled substance abuse treatment program.
16:19
Unidentified speaker: Some they may have been dealing with a substance abuse issue for quite some time and they're ready.
16:23
Unidentified speaker: Um scope will flag that we need to enroll that patient into a program and also prescribe Suboxone, which is a controlled substance.
16:32
Unidentified speaker: Those two are two different um diagnoses and orders that uh can then be enabled by a provider on the back.
16:42
Unidentified speaker: And we can coordinate um the right amount of time by the right provider to make sure that those orders turn into treatments as least as possible.
16:51
Unidentified speaker: So for instance, for the broad spectrum antibiotics, uh a physician can have a standing order, whereas a patient that has certain parameters, um, they're okay with having those antibiotics issued immediately.
17:03
Unidentified speaker: And that case manager can literally reach into their bag and give those antibiotics right then.
17:07
Unidentified speaker: But Suboxone, a controlled substance, yeah, a little bit different workflow there, different workflow there.
17:12
Unidentified speaker: So that separate workflow starts where immediately that patient can enter into a virtual face-to-face conversation with a with a f a physician, and can ask any follow-up questions, gain clarity, and then issue that that order, issue that uh that that that prescription.
17:29
Unidentified speaker: What are some of the uh because I'm sure there's uh got to be a few, but what where are the limitations on where scope can go?
17:34
Unidentified speaker: Uh when does it just flag that we have to get uh physician you know in the loop on this issue?
17:41
Unidentified speaker: Well, so uh what I want to note that we we maintain physicians in the in the loop on all everything.
17:48
Unidentified speaker: Right.
17:48
Unidentified speaker: And again, that might mean uh a situation where a physician has a pre-approved order set.
17:54
Unidentified speaker: Uh that might mean that the actual next step activity didn't require a physician, it requires a task, you know.
18:00
Unidentified speaker: Um or that might mean an urgent escalation where uh a physician needs to be brought uh that patient needs to be brought to a physician immediately for a life for a life-saving circumstance.
18:11
Unidentified speaker: Um and so the uh you know the uh in in terms of clinical uh capability um uh we're in a fortunate position because of just the our sheer number of patients and cases that we we have.
18:28
Unidentified speaker: I mean, our our our system, our health system takes care of about a million patients.
18:32
Unidentified speaker: So if you put that in context, that's roughly twice the size of one medical, one public.
18:38
Unidentified speaker: Um and uh as a result of that, we have a tremendous amount of documented clinical cases.
18:43
Unidentified speaker: So we measure the effectiveness of scope from a clinical accuracy point of view against the history of those cases.
18:50
Unidentified speaker: It's called total addressable medical situation space.
18:53
Unidentified speaker: It's actually a unique advantage that we have because we have so many different kinds of cases across different specialties.
18:58
Unidentified speaker: And scope performs at like a 93.6% against that.
19:03
Unidentified speaker: So um, you know, I think twice as high as a frontier model, um, focused on a healthcare context.
19:12
Unidentified speaker: Um and so clinically speaking, uh, it's very accurate and very expansive.
19:18
Unidentified speaker: And it's also a multi-specialist, right?
19:20
Unidentified speaker: So you're not, you know, it's not just a cardiologist or just an endocrinologist.
19:24
Unidentified speaker: Uh it's taking a true multi-specialty approach to that um upstream clinical investigation process.
19:32
Unidentified speaker: Uh but just as importantly, right, is that coordination layer is that bringing the physician in the loop for the right level of uh time for the right situation, for the right moment, making sure that the circumstance is brought to that physician in the right way.
19:46
Unidentified speaker: So you said a million patients.
19:48
Unidentified speaker: I I think I read that you have 96 or so locations, I guess primarily in California and Rhode Island and a little bit of New York.
19:55
Unidentified speaker: Is that right?
19:56
Unidentified speaker: That's right.
19:56
Unidentified speaker: Yeah.
19:57
Unidentified speaker: So when I when I think about the acuity level of one of these, uh one of your patients being high or there's something that maybe scope can't handle, how do you partner with the local health care system to do, I don't know, do surgery or get a cardiac intervention or those sorts of things?
20:13
Unidentified speaker: I mean we're just you can think about us from that lens, just like a health system.
20:17
Unidentified speaker: Okay.
20:18
Unidentified speaker: We're a health system.
20:19
Unidentified speaker: Um and we're a health system that you know has commercial, sees co-sees patients that are commercially insured, Medicare and Medicaid.
20:26
Unidentified speaker: Um, and pretty normal that way.
20:28
Unidentified speaker: 50% of our patients are commercial, 25% of our patients are Medicare, 25% of our patients are Medicaid.
20:34
Unidentified speaker: We focus on outpatient care.
20:36
Unidentified speaker: So primary care and specialty care in an outpatient contact.
20:39
Unidentified speaker: We do have proceduralists as well.
20:41
Unidentified speaker: Uh, but generally, when a patient needs a procedure, we're going to be referring them to a local partnering healthcare system.
20:48
Unidentified speaker: For instance, Pomona Valley Hospital is uh probably our biggest partner in the Pomona region.
20:53
Unidentified speaker: We have a really close relationship.
20:54
Unidentified speaker: It's an amazing organization.
20:56
Unidentified speaker: Um it's a community-focused nonprofit organization, uh, level one trauma center.
21:02
Unidentified speaker: And, you know, our teams and our doctors and our providers work hand in hand with um that health system to to you know bring the best that we can to that to that community.
21:13
Unidentified speaker: And that's really kind of how how how we see it.
21:15
Unidentified speaker: You know, I think that we want to be the point guard of care for um for these patients, um, be their their their their trusted partner for um for all their circumstances and make sure that when and if they need a an emergency procedure or any kind of procedure that we're directing them to the right place.
21:37
Unidentified speaker: But also preventing that, being as preventative as possible.
21:41
Unidentified speaker: So for I you know, for we're very proud of our street medicine program.
21:45
Unidentified speaker: Um I think we have the largest operational street medicine program in California.
21:49
Unidentified speaker: Um and you know, because we're able to send um our colleagues into the field on a regular basis, um, whether it's care managers or whether it's caseworkers, uh, armed by scope, we can do ongoing in-the-field evaluation on a much more frequent basis.
22:11
Unidentified speaker: Um and this is a patient population that's gonna have a really challenging time coming into any physical location, no matter how many appointments that we have.
22:20
Unidentified speaker: Uh and so by doing that field-based evaluation, that clinical investigation process powered by scope, you're able to monitor them for emergent diseases on a much more frequent basis, right?
22:32
Unidentified speaker: Um and so hopefully we're, you know, in general, they're just going to be uh having less procedures.
22:39
Unidentified speaker: And we've seen that.
22:40
Unidentified speaker: I know I think that uh patients in our street medicine program uh have a 50% reduction in e-utilization.
22:47
Unidentified speaker: Um I think you know 80% uh can be enrolled in a substance abuse program if eligible.
22:54
Unidentified speaker: So there's uh if eligible and if if necessary.
22:56
Unidentified speaker: So the outcomes data when you can do clinical investigation on a more frequent basis that results in a treatment is extraordinarily compelling.
23:07
Unidentified speaker: What what sort of KPIs or performance indicators do you look at, maybe you know, outside of the street program?
23:12
Unidentified speaker: I'm thinking more of the run-of-the-mill commercial or Medicare.
23:16
Unidentified speaker: Honestly, it's just a normal healthcare system.
23:20
Unidentified speaker: We look at typical quality pro quality metrics, uh, typical utilization management metrics.
23:26
Unidentified speaker: Um I mean, we've we've really focused our health system.
23:29
Unidentified speaker: Um while we acknowledge that most of American healthcare is still within a fee-for-service construct, sure.
23:36
Unidentified speaker: Um, we feel strongly that uh true value-based care, not just optimizing, you know, uh here and there to to manage utilization, but really uh preventative, prevention-focused value-based care um is uh the model of the future.
23:52
Unidentified speaker: And so we've oriented uh our organization towards that that that future.
23:57
Unidentified speaker: So we track things like ongoing quality, patient satisfaction, I think we have 96% 96 NPS um score on our scope and able care model.
24:06
Unidentified speaker: So normal stuff that the health system is tracking, but um looking at it from uh also a dimension of how what is our cost per treatment, what is our cost per clearance, our cost per diagnosis?
24:19
Unidentified speaker: Are we driving that down?
24:20
Unidentified speaker: Are we increasing the capacity on not just our providers, but also other parts of our healthcare system?
24:27
Unidentified speaker: Um, you know, there's a lot of pieces that come together when you're doing uh a whole healthcare system as opposed to just the virtual care model, right?
24:35
Unidentified speaker: Um and so we're tracking all of those indicators as well.
24:39
Unidentified speaker: Okay.
24:40
Unidentified speaker: Yeah, I was trying to get at you know where you benchmark yourselves against maybe traditional healthcare systems and where you see where you see the greatest returns are ROI versus that traditional model.
24:50
Unidentified speaker: Yeah.
24:51
Unidentified speaker: I mean, at the end of the day, it's going to be um you know how many patients can we handle on a network basis?
25:01
Unidentified speaker: Um, and you know, can we increase um not just the capacity on a per provider basis, uh, but uh the the uh amount of um touch points that a patient gets on a per provider basis.
25:20
Unidentified speaker: Um generally it's kind of one or the other.
25:22
Unidentified speaker: If you're trying to increase throughput or capacity on a per-provider basis, uh an individual patient might not get the same level of uh comprehensive clinical attention.
25:33
Unidentified speaker: Um in this model, we're uh able to increase the amount of touch points, the amount of visibility we're getting on a patient, the uh the kinds of care we can provide that patient, as well as increase the capacity of our provider network.
25:51
Unidentified speaker: Um, because again, you're optimizing uh different kinds of providers' time to make sure that they're spending that time on where they're most necessary, where it's most useful, as opposed to somebody having to uh do like a general conversation every single time just to arrive at, okay, well, I didn't really need to spend all that time with that patient.
26:10
Unidentified speaker: Uh that patient needed a care task, and now that patient's not going to get that today because we spent 15 minutes talking about the local sports team or something.
26:19
Unidentified speaker: I mean, we want to make a well we're we're building a more human um focused health system.
26:25
Unidentified speaker: Um, you know, we're not a chat bot.
26:27
Unidentified speaker: It's not deployed as a chat bot.
26:29
Unidentified speaker: It can be a chat bot, but it's not deployed as a chat bot.
26:31
Unidentified speaker: Um the goal is to be able to have patients feel like they're getting um more time to talk about their health concerns.
26:40
Unidentified speaker: Um there's more attention spent on them, not you know, uh not a model where you know it's less and they're just having to speak to an app on their phone.
26:52
Unidentified speaker: Um and in the same way, you know, we want a provider, uh, when they are interacting with that patient directly, uh, in any circumstance, be able to spend more time asking about the relevant questions to have a deeper understanding, have more context up front about that patient.
27:07
Unidentified speaker: So it's not like spending 15 minutes just to understand like, let me get some orientation here, you know.
27:14
Unidentified speaker: More human uh, but also optimizing humans so that we can take care of our patient by force.
27:20
Unidentified speaker: I wanted to come back to something you said earlier about scope outperforming the frontier models.
27:24
Unidentified speaker: And I guess what do you see as the advantage there?
27:28
Unidentified speaker: And is it the models, is it the data, the your your own EHR, the whole collection?
27:33
Unidentified speaker: And the reason I asked is it's interesting.
27:34
Unidentified speaker: We had the CEO of Datavan on recently, and he mentioned that the frontier models only have access to 7%, I think was the number he quoted of healthcare data.
27:43
Unidentified speaker: Yeah.
27:44
Unidentified speaker: Which seems like if you had the stack and that that proprietary data, you're one step ahead.
27:50
Unidentified speaker: Yeah, I think that there it is the data.
27:52
Unidentified speaker: And what does that mean?
27:54
Unidentified speaker: That means a lot of different things.
27:55
Unidentified speaker: Um I think one is the corpus of data um that we've amassed from the first you know, five years of our painstaking journey of creating uh a huge compilation of information that's organized, longitudinal, um, usable for both back then initially it was machine learning and predictive analytics, like again, AI as it is today, still relatively new.
28:19
Unidentified speaker: Um and so that data set, number one, um, you can think about that as we have built what is, to my knowledge, the country's largest comprehensive medical textbook.
28:31
Unidentified speaker: And yeah, I don't know another place where you could find that.
28:34
Unidentified speaker: The second thing um is we have you know, because we have our own electronic health record system uh and we're cap been capturing information, speech to text for for for a while.
28:46
Unidentified speaker: Um you're uh and because we have so many different kinds of providers, you know, endocrinology, cardiology, rheumatology, um, in our healthcare facilities, uh we see a we have a lot of case history, right?
29:00
Unidentified speaker: Case history of what a provider went through to be able to arrive at a diagnosis.
29:05
Unidentified speaker: Um and you know, it's hundreds of thousands of real um cases that a that represent not just patient presents with and what the diagnosis was, but what was the investigative process that a physician went through in a certain circumstance?
29:23
Unidentified speaker: Um that's kind of like having an amazing, you know, scoreboard on if you're creating a model, did you go that model go through that situation accurately or not?
29:34
Unidentified speaker: Uh and that lets us create that TAMS framework, that total addressable medical situation space framework.
29:40
Unidentified speaker: And the third thing is that we have um a massive uh reinforcement learning apparatus, um, meaning that we have providers that are and other team members, not just providers, um, but other team members that are in our health system that are interacting with what models suggest uh directly or are running in shadow mode.
30:04
Unidentified speaker: And so if uh a model suggests something and in sh in shadow mode, let's say, um, kind of like when Tesla is uh is running in the background while you're driving your car, right?
30:16
Unidentified speaker: Uh and you, you know, you that that um that team member does something different than what the model might protect, that's a reinforcement learning loop that is really, really difficult to find.
30:28
Unidentified speaker: And so we have you know an active reinforcement learning loop across various aspects of our healthcare system.
30:35
Unidentified speaker: Uh and so, you know, in sum, we have the country's largest medical textbook, two, we have uh the best and most widespread grading rubric on whether or not Mattles uh do well or poorly.
30:48
Unidentified speaker: And three, we have uh like, I don't know, the country's largest multi-specialty residency program um that is able to train our models.
30:59
Unidentified speaker: And so uh all of that comes into data.
31:01
Unidentified speaker: It's all it's all either feedback or grading or just raw material to be able to train models.
31:07
Unidentified speaker: And I think frontier model technology will keep getting better and better and better and better, which is great, uh, but our data becomes the competitive advantage.
31:15
Unidentified speaker: What stops, I I guess maybe this is simplistic, but what stops a large help system from you know mirroring what you're trying what you've been doing for the last 10 years?
31:24
Unidentified speaker: There's a few different things.
31:25
Unidentified speaker: One is um just purely from a data standpoint, even when we were at GEC Medicine, it was very clear that we need a lot more data to build technology like this.
31:36
Unidentified speaker: Okay.
31:37
Unidentified speaker: So there is a a core advantage that organizations like us have.
31:43
Unidentified speaker: Um number two is a lot of health systems um are focused on procedural um work.
31:54
Unidentified speaker: And that's what both drives the economics of the systems and uh where ultimately where they have the most competitive advantage.
31:59
Unidentified speaker: If you're investing in uh creating a you know a you know big surgical space, you want to monetize that surgical space and um you know it's it's where you're gonna be able to um create the most value within that particular community.
32:13
Unidentified speaker: Um reorienting operations uh in an inpatient sense is different.
32:19
Unidentified speaker: It's not just uh awareness of what might happen to a you know a patient or you know, upstream awareness.
32:26
Unidentified speaker: Uh it's reorienting how the operations around a set of procedures works or how an ED works.
32:32
Unidentified speaker: That's a physical problem as much as it is an awareness problem.
32:35
Unidentified speaker: Okay.
32:36
Unidentified speaker: Um and number three is you know, we have you know the best technologists in the world.
32:42
Unidentified speaker: Like we've built a you know a keto is like Waymo in the sense that we have a full-scale RD organization and a full-scale operating multi-specialty healthcare organization.
32:57
Unidentified speaker: Um that RD organization is you know bringing some of the world's best talent uh to tackle these problems directly.
33:07
Unidentified speaker: And uh, you know, I I think that health systems right now, um, while everyone's trying to do better and you know bring better technology and programs and tools into the world, they're not necessarily oriented for that kind of work.
33:22
Unidentified speaker: That makes sense.
33:23
Unidentified speaker: One of the things you mentioned was um this, I guess, divergence between maybe like what a shadow model says and and what actually the the provider does.
33:32
Unidentified speaker: How do you think about liability in the scope of your models and your decision support?
33:38
Unidentified speaker: Yeah.
33:38
Unidentified speaker: Um well, clinically speaking, uh, we're a physician in the loop model.
33:43
Unidentified speaker: Um that alleviates the the very high level.
33:46
Unidentified speaker: Yeah, that's the you know, the the uh the the liability is carried with providers and you know there's just think about it as like a typical healthcare organization, right?
33:54
Unidentified speaker: Um this is specifically designed to be clinical decision support, um, not you know a replacement of a clinician's judgment.
34:04
Unidentified speaker: Okay.
34:04
Unidentified speaker: Um it's very important.
34:06
Unidentified speaker: That's great to clarify.
34:08
Unidentified speaker: Yeah.
34:08
Unidentified speaker: Um and part of that's really important, uh, you know, because uh we believe strongly that we want to bring this into the world today.
34:19
Unidentified speaker: You know, we need to be able to bring this technology into the world today so that we can help these providers, you know, take care of more and more patients in a way that is uh gonna be aligned with, you know, why they got the game in the first place, honestly.
34:34
Unidentified speaker: Yeah.
34:35
Unidentified speaker: That's why my mom is still a doctor, you know, still doing like volunteer work at the age of 70 plus.
34:41
Unidentified speaker: And so, you know, that's uh a core part of how we've designed our system.
34:46
Unidentified speaker: Uh the second part about it is that we are capturing an immense amount of detail uh across uh so many different dimensions of a patient's journey.
34:56
Unidentified speaker: And I think that we can have much more visibility into where um and how we can do better care in the future or where care might have gone wrong than I think ever before.
35:08
Unidentified speaker: Um and that's a combination of uh being able to have so much more um time to do clinical investigation of these different dimensions of care.
35:17
Unidentified speaker: As it as uh in in addition to being able to uh you know control the entire digital backbone of the healthcare system within one piece of technology, right?
35:29
Unidentified speaker: So we're not missing something.
35:31
Unidentified speaker: You know, we're learning more about a patient up front, we're learning more dimensions about a patient, um, which might be challenging if a patient's coming in to see you know four different specialists over the course of a year, let's say, uh in a fragmented way.
35:45
Unidentified speaker: Uh and also all of that's being tracked and quantified and kept within uh a single source of truth.
35:52
Unidentified speaker: Um so I bring that up in the liability context because I think visibility is a key part of um being able to maintain a high level of accountability to us as a health system operator and also our providers.
36:07
Unidentified speaker: That makes a ton of sense.
36:08
Unidentified speaker: You know, if I think about where you want to be in in five years, how do you think about your roadmap?
36:13
Unidentified speaker: I mean, I think you did a capital raise last year.
36:16
Unidentified speaker: You know, what's next for a keto apps?
36:19
Unidentified speaker: This is a important time to be able to bring um highly available, highly personalized care into the world.
36:27
Unidentified speaker: Um, you know, partially we we're all aware of changes that are happening in the Medicaid ecosystem.
36:32
Unidentified speaker: And you know, I think for the first time in um uh healthcare's, you know, modern history, uh is it is it is it is there a yearning for change, real change, you know.
36:46
Unidentified speaker: I think people, whether it's providers, whether it's health systems, they see the uh you know the potential of artificial intelligence.
36:55
Unidentified speaker: Um, you know, amazing companies like a bridge have done tremendous job in bringing uh you know and and sort of solving these uh these clinical administrative problems.
37:05
Unidentified speaker: And so I think that it's created uh a softer shell, so to say, um, in driving change within these um these uh these jobs it's created a softer shell in being able to bring technology into the world.
37:20
Unidentified speaker: Um Akido is in a unique position.
37:23
Unidentified speaker: We're we're significant, we're part of the American healthcare tapestry.
37:27
Unidentified speaker: Healthcare America works with us, whether you like it or not, at this point.
37:31
Unidentified speaker: And uh, you know, we have a uh an answer to um the increasing uh load that providers will face with changes in Medicaid.
37:45
Unidentified speaker: Um and so while there is a s an appetite for change and a need for for change, um, we want to propagate our system to as many geographies as possible.
37:59
Unidentified speaker: So um, you know, our goal is to get to 50 markets in the next five years.
38:05
Unidentified speaker: That's great.
38:06
Unidentified speaker: What does it take to stand up and do geography?
38:09
Unidentified speaker: So typically we'll start with partners within a particular ecosystem.
38:13
Unidentified speaker: Okay.
38:14
Unidentified speaker: Um, you know, as we're uh preparing to expand into the New York region, for instance, uh our partners here include the Independent Drivers Guild, um the Workers Benefit Fund, amazing organizations that are trying to do their best to bring benefits and programs and support services to some of um New York's, you know, most um most in need uh patients and citizens, which is uh or or uh residents, most some of New York's most in-need residency uh are Uber and Lyft drivers.
38:47
Unidentified speaker: And being able to partner with them to imagine what an optimal care model for this patient population might look like, something that's highly available, highly personalized, like that's where we start.
38:59
Unidentified speaker: Um and then as we figure out what that care model looks like, we'll make sure that we have the support locally to be able to deliver on that on that care model.
39:10
Unidentified speaker: Um and then off the races.
39:14
Unidentified speaker: Well said.
39:15
Unidentified speaker: When when from your seat, you know, you're at this forefront of technology and innovation, you know, and in how we deliver care.
39:22
Unidentified speaker: What is going to surprise the listener, you know, five years from now that we're we're doing in healthcare that we're not doing today?
39:29
Unidentified speaker: In five years in healthcare, every single person in America will have the same kind of quality of healthcare that Jeff Bezos has.
39:39
Unidentified speaker: Um and uh that is going to be made available um combination of uh technologies like artificial intelligence as well as monitoring technologies, whether it's wearables or more medical-grade wearables that will constantly be monitoring what's happening to you and be able to intervene earlier and earlier and earlier uh through a combination of that signal, of that processing, of clinicians that are gonna be thinking about managing populations like field generals and being able to uh issue prescriptions and treatments um in uh in such a quick manner that's gonna be incomprehensible to us.
40:23
Unidentified speaker: The idea of waiting for three months for a cardiology visit is gonna be completely outdated.
40:30
Unidentified speaker: And that is just not where healthcare is today.
40:32
Unidentified speaker: The irony, I I I just went to a cardiologist yesterday, and I think I waited four or five months.
40:38
Unidentified speaker: Yeah.
40:38
Unidentified speaker: So I I'm ready for the Jeff Bezos model of healthcare.
40:43
Unidentified speaker: Yeah, I mean, I think that um there is a practical abundance coming.
40:52
Unidentified speaker: Um and use that word practical because I think it's technically there right now.
40:57
Unidentified speaker: Practically blocked.
40:59
Unidentified speaker: And I think in five years uh the flood of that is gonna be impossible to stop.
41:03
Unidentified speaker: And what's the key unlock there?
41:05
Unidentified speaker: You know, what's gonna What's the catalyst to I guess maybe flip that switch and unlock all of this?
41:11
Unidentified speaker: Um I think it's two things.
41:13
Unidentified speaker: I think it's um, you know, we touched on it earlier.
41:16
Unidentified speaker: I think that historically it's either been you see more patients or you get more time to understand what happens to a patient.
41:26
Unidentified speaker: Um and that more time could be because, you know, let's say in a concierge care model, you're guys focusing on one patient, you're having them do tons and tons of testing, and you're getting a much more comprehensive understanding of the world.
41:38
Unidentified speaker: I think that the combination of um more and more wearable technology, more and more uh highly available diagnostics um that are gonna be cheaper and cheaper, coupled with um active investigation.
41:53
Unidentified speaker: Uh, it feeds into a wide variety of neural network models like Scope AI.
41:58
Unidentified speaker: Um, you're gonna be able to monitor a lot more about what happens to a patient and also see a lot more patients.
42:06
Unidentified speaker: Easy.
42:07
Unidentified speaker: And uh and so I think that that that is the critical change that's happening in the world.
42:12
Unidentified speaker: I think that makes true value-based care just a practical reality and so obviously the most efficient way of taking care of patient population that no amount of kind of legacy orientation or you know, politics are gonna be able to see.
42:28
Unidentified speaker: I think that's a that's a good good note to end on from the formal perspective.
42:32
Unidentified speaker: One of the ways I like to wrap these conversations up is I always ask our guests, Zippa, you know, something on a personal note, is there a lesson from, you know, your a key lesson from your personal or professional life that you see driving your what you see as your mission or North Star?
42:47
Unidentified speaker: I think it's unconscionable that I have been able to live this life where, you know, because of the good fortune of my education, because of the good fortune of, you know, parents that sacrificed an immense amount to, you know, come from India to America to work in, you know, uh in great jobs, but challenging jobs.
43:12
Unidentified speaker: Um, you know, to to give me education means housing.
43:16
Unidentified speaker: Uh like those early developmental things are the reason that I'm able to have this conversation with you here in this lovely, you know, Bloomberg living embodiment of a Bloomberg terminal was what it feels like to me.
43:28
Unidentified speaker: Um I think it's unconscionable um that, you know, in a world where we have so much um that it's uh reserved for me.
43:37
Unidentified speaker: Um I think that being able to bring that kind of developmental support, healthcare, and otherwise to um, you know, all of our fellow humans is why everybody works here, why I work here.
43:51
Unidentified speaker: Very well said and a very commendable mission.
43:53
Unidentified speaker: Thank you for sharing.
43:54
Unidentified speaker: Thank you.
43:55
Unidentified speaker: All right, and thank you uh so much for giving us a deep dive on Akido Labs.
43:59
Unidentified speaker: It's fascinating.
44:00
Unidentified speaker: I can't wait to see where you guys go next.
44:01
Unidentified speaker: It's nice to have with you.
44:03
Unidentified speaker: That's Prashant Simant, CEO and co-founder of Akido.
44:06
Unidentified speaker: Thank you for listening to this episode of the Vanguards of Healthcare podcast.
44:09
Unidentified speaker: And don't forget to click the follow button on your favorite podcast app or website so you never miss an interview with the weeders rewriting the playbook on healthcare innovation.
44:17
Unidentified speaker: Until next time, take care of the colour.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3 and interpreted by Qwen3.6-35B-A3B-GGUF:UD-Q4_K_XL. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from Vanguards of Healthcare by Bloomberg Intelligence

All insights